Epicardial implantation of a lumenless active fixation lead in a neonate-Reference-Cited by-同舟云学术

Epicardial implantation of a lumenless active fixation lead in a neonate

Published:2023-05-14 Issue:11 Volume:46 Page:1366-1369
ISSN:0147-8389
Container-title:Pacing and Clinical Electrophysiology
language:en
Short-container-title:Pacing Clinical Electrophis

Author:

Zhang Jianghua¹,Dong Zhenyu¹^ORCID,Ma Songfeng²,Abdukadir Ablat³,Tang Baopeng¹,Xu Yuanning⁴

Affiliation:

1. Department of Cardiac Pacing and Electrophysiology The First Affiliated Hospital of Xinjiang Medical University & Xinjiang Key Laboratory of Cardiac Electrophysiology and Remodeling The First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang China

2. Department of Pediatric Cardiothoracic Surgery The First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang China

3. Department of Neonatal Intensive Care Medicine The First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang China

4. Department of Cardiology West China Hospital of Sichuan University Chengdu Sichuan China

Abstract

AbstractBackgroundWe present a case of epicardial pacemaker implantation in a low birth weight newborn using a lumenless active fixation lead.ResultsWe found that superior pacing parameters can be obtained by implanting a lumenless active fixation lead into the epicardium, but more evidence is needed to support this hypothesis.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pace.14681

Reference4 articles.

1. Outcomes in congenital and childhood complete atrioventricular block: A meta‐analysis

2. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement

3. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE

4. Novel Doppler‐guided subxyphoid approach to avoid coronary artery damage during left ventricular epicardial lead placement or ablation